GB0505076D0 - Medicament and treatment for herpes simplex and other infections - Google Patents

Medicament and treatment for herpes simplex and other infections

Info

Publication number
GB0505076D0
GB0505076D0 GBGB0505076.0A GB0505076A GB0505076D0 GB 0505076 D0 GB0505076 D0 GB 0505076D0 GB 0505076 A GB0505076 A GB 0505076A GB 0505076 D0 GB0505076 D0 GB 0505076D0
Authority
GB
United Kingdom
Prior art keywords
infections
medicament
treatment
herpes simplex
simplex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0505076.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GBGB0505076.0A priority Critical patent/GB0505076D0/en
Publication of GB0505076D0 publication Critical patent/GB0505076D0/en
Priority to EP06726355A priority patent/EP1861088A1/en
Priority to JP2008500267A priority patent/JP2008543730A/en
Priority to PCT/GB2006/000845 priority patent/WO2006095178A1/en
Priority to CNA2006800118064A priority patent/CN101155581A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0505076.0A 2005-03-11 2005-03-11 Medicament and treatment for herpes simplex and other infections Ceased GB0505076D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0505076.0A GB0505076D0 (en) 2005-03-11 2005-03-11 Medicament and treatment for herpes simplex and other infections
EP06726355A EP1861088A1 (en) 2005-03-11 2006-03-10 Medicament and treatment for herpes simplex
JP2008500267A JP2008543730A (en) 2005-03-11 2006-03-10 Drugs and treatment for herpes simplex
PCT/GB2006/000845 WO2006095178A1 (en) 2005-03-11 2006-03-10 Medicament and treatment for herpes simplex
CNA2006800118064A CN101155581A (en) 2005-03-11 2006-03-10 Medicament and treatment for herpes simplex

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0505076.0A GB0505076D0 (en) 2005-03-11 2005-03-11 Medicament and treatment for herpes simplex and other infections

Publications (1)

Publication Number Publication Date
GB0505076D0 true GB0505076D0 (en) 2005-04-20

Family

ID=34508938

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0505076.0A Ceased GB0505076D0 (en) 2005-03-11 2005-03-11 Medicament and treatment for herpes simplex and other infections

Country Status (5)

Country Link
EP (1) EP1861088A1 (en)
JP (1) JP2008543730A (en)
CN (1) CN101155581A (en)
GB (1) GB0505076D0 (en)
WO (1) WO2006095178A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0815179D0 (en) * 2008-08-20 2008-09-24 Sharma Anant Medication and treatment for infection
GB201015305D0 (en) * 2010-09-14 2010-10-27 Ucl Business Plc Methods, compounds and compositions relating to activating a latent virus
WO2015077774A1 (en) * 2013-11-25 2015-05-28 Saint Louis University Inhibitors of hsv nucleotidyl transferases and uses therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994388A (en) * 1997-03-18 1999-11-30 The Children's Medical Center Corporation Cytochalasin and isoindolinone derivatives as inhibitors of angiogenesis

Also Published As

Publication number Publication date
CN101155581A (en) 2008-04-02
JP2008543730A (en) 2008-12-04
EP1861088A1 (en) 2007-12-05
WO2006095178A1 (en) 2006-09-14

Similar Documents

Publication Publication Date Title
IL250858A0 (en) Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
HK1221956A1 (en) Halogen-substituted boronophthalides for the treatment of infections
EP1903936A4 (en) Medication compliance system and associated methods
EP1912650B8 (en) Use of flibanserin in the treatment of obesity
GB0516069D0 (en) Pharmaceutical and use thereof
IL208070A0 (en) Myxoma virus mutants for therapeutic treatment
PT1945243E (en) Use of calcitonin for the treatment of ra
AU2006251169A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
AU2006251167A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
IL180487A0 (en) Medicament
EP2005964A4 (en) The medicament for treating hyperphospheremia and preparation thereof
GB0505076D0 (en) Medicament and treatment for herpes simplex and other infections
EP2077117A4 (en) Agent exhibiting immunoregulatory properties and the use thereof for treating autoimmune diseases
GB0415181D0 (en) Compounds for use in the treatment of infection
GB0505964D0 (en) Products and methods for treating vaginal infections
IL185575A0 (en) Benzoxazocines and their therapeutic use
PL2117563T3 (en) Amidinoanthracycline antibiotics for use in the treatment of viral infections
GB0308603D0 (en) Pharmaceutical combinations for treating viral infections
GB0308604D0 (en) Pharmaceutical combinations for treating viral infections
GB0517617D0 (en) Treatment using herpes simplex virus
HK1125634A1 (en) Pharmaceutical for use in the treatment of ureterolithiasis
GB0514849D0 (en) Treatment for kerationlytic and other fungal infections
AU2005902412A0 (en) Medicinal treatment
HK1217641A1 (en) Formulations and methods for treating chronic infection
GB0409098D0 (en) Medicament

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)